Background Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not
been extensively evaluated. Methods We conducted a randomized, placebo-controlled trial …

In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with
the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human …

Objective. Systemic sclerosis-associated interstitial lung disease (SSc-ILD) shares a
number of clinical features and pathogenic mechanisms with idiopathic pulmonary fibrosis (IPF). …

Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM).
Methods Expert surveys, logistic regression, and conjoint analysis were used to develop …

Objective T cells play a key role in the pathogenesis of early systemic sclerosis. This study
was undertaken to assess the safety and efficacy of abatacept in patients with diffuse …

Objective To assess cumulative survival rates and identify independent predictors of
mortality in patients with incident systemic sclerosis (SSc)–associated pulmonary arterial …

Objective Early diffuse cutaneous systemic sclerosis (dcSSc) is characterized by rapid changes
in the skin and internal organs. The objective of this study was to develop a composite …

Introduction The idiopathic inflammatory myopathies are rare diseases for which data regarding
the natural history, response to therapies and factors affecting mortality are needed. We …

Background There is a scarcity of research regarding the effectiveness of the mRNA-1273 (Moderna)
and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in patients taking …

Objective. Pulmonary arterial hypertension (PAH) increases mortality in systemic sclerosis (SSc).
The multicenter PHAROS registry (Pulmonary Hypertension Assessment and …